SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001144204-17-056330
Filing Date
2017-11-06
Accepted
2017-11-06 06:05:23
Documents
1
Group Members
FORESITE CAPITAL FUND IV, L.P.FORESITE CAPITAL MANAGEMENT III, LLCFORESITE CAPITAL MANAGEMENT IV, LLCJAMES TANANBAUM

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G tv478696_sc13g.htm SC 13G 93461
  Complete submission text file 0001144204-17-056330.txt   95359
Mailing Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560
Business Address 7999 GATEWAY BLVD SUITE 130 NEWARK CA 94560 510-293-8800
CymaBay Therapeutics, Inc. (Subject) CIK: 0001042074 (see all company filings)

IRS No.: 943103561 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-87950 | Film No.: 171178127
SIC: 2834 Pharmaceutical Preparations

Mailing Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111
Business Address 600 MONTGOMERY STREET SUITE 4500 SAN FRANCISCO CA 94111 415-877-4887
Foresite Capital Fund III, L.P. (Filed by) CIK: 0001645158 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G